Resources & Guides

Semaglutide has three published human trials on drinking. One met its primary endpoint, one missed it outright, one met its laboratory endpoint but not its real-world measures. Neither the Ozempic nor the Wegovy label says anything about drinking alcohol.

Tirzepatide is FDA-approved as Mounjaro and Zepbound, so you might assume alcohol has been studied. It has not. The prescribing information never addresses drinking at all. Here is what the label does say, and what that leaves you to reason about yourself.

There is no formal drug-drug interaction study between retatrutide and alcohol. What we have is a clear pharmacological mechanism, one peer-reviewed animal study, and class-level precedent from approved GLP-1 drugs. Here is what the evidence actually says.